Nyt fra tidsskrifterne
Ingen søgeord valgt.
20 emner vises.
1
Endoscopic findings of laryngitis caused by SARS-CoV-2/Omicron variant infection
Infection
Tilføjet 27.01.2023
2
Correction: Nevirapine hair and plasma concentrations and HIV-1 viral suppression among HIV infected ante-partum and post-partum women attended in a mother and child prevention program in Maputo city, Mozambique
PLoS One Infectious Diseases
Tilføjet 27.01.2023
3
Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies
PLoS One Infectious Diseases
Tilføjet 27.01.2023
4
Scoping review of cytolytic vaginosis literature
PLoS One Infectious Diseases
Tilføjet 27.01.2023
5
Awareness and perceptions of Long COVID among people in the REACT programme: Early insights from a pilot interview study
PLoS One Infectious Diseases
Tilføjet 27.01.2023
6
A statistical model for early estimation of the prevalence and severity of an epidemic or pandemic from simple tests for infection confirmation
PLoS One Infectious Diseases
Tilføjet 27.01.2023
7
A study on tuberculosis disease disclosure patterns and its associated factors: Findings from a prospective observational study in Chennai
PLoS One Infectious Diseases
Tilføjet 27.01.2023
8
Early antiretroviral therapy reduces severity but does not eliminate neurodevelopmental compromise in children with HIV
Journal of Acquired Immune Deficiency Syndromes
Tilføjet 27.01.2023
9
Role of non‐coding RNAs with emphasis on long non‐coding RNAs as cervical cancer biomarkers
Journal of Medical Virology
Tilføjet 27.01.2023
10
Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019
Journal of Medical Virology
Tilføjet 27.01.2023
11
[World Report] “Unfettered flow”: how ProMED-mail keeps the world alert
Lancet
Tilføjet 27.01.2023
12
[Articles] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Lancet
Tilføjet 27.01.2023
13
[Articles] Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Lancet
Tilføjet 27.01.2023
14
Low protease activity in B cell follicles promotes retention of intact antigens after immunization
Science
Tilføjet 27.01.2023
15
A vaccine sanctuary in the lymph node
Science
Tilføjet 27.01.2023
16
Infection infidelities drive innate immunity
Science
Tilføjet 27.01.2023
17
Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV
New England Journal of Medicine
Tilføjet 26.01.2023
18
Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
New England Journal of Medicine
Tilføjet 26.01.2023
19
Effectiveness of Bivalent Boosters against Severe Omicron Infection
New England Journal of Medicine
Tilføjet 26.01.2023
20
Towards a general, worldwide, Plasmodium population genomics framework
Trends in Parasitology
Tilføjet 26.01.2023